These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

507 related articles for article (PubMed ID: 12970784)

  • 21. T cell receptor gamma gene rearrangements as targets for detection of minimal residual disease in acute lymphoblastic leukemia by real-time quantitative PCR analysis.
    van der Velden VH; Wijkhuijs JM; Jacobs DC; van Wering ER; van Dongen JJ
    Leukemia; 2002 Jul; 16(7):1372-80. PubMed ID: 12094263
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Minimal residual disease (MRD) monitoring using rearrangement of T-cell receptor and immunoglobulin H gene in the treatment of adult acute lymphoblastic leukemia patients.
    Toubai T; Tanaka J; Ota S; Fukuhara T; Hashino S; Kondo T; Kasai M; Kakinoki Y; Masauzi N; Morioka M; Kawamura T; Iwasaki H; Asaka M; Imamura M
    Am J Hematol; 2005 Nov; 80(3):181-7. PubMed ID: 16247752
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98-3936.
    van Dongen JJ; Langerak AW; Brüggemann M; Evans PA; Hummel M; Lavender FL; Delabesse E; Davi F; Schuuring E; García-Sanz R; van Krieken JH; Droese J; González D; Bastard C; White HE; Spaargaren M; González M; Parreira A; Smith JL; Morgan GJ; Kneba M; Macintyre EA
    Leukemia; 2003 Dec; 17(12):2257-317. PubMed ID: 14671650
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Implementation of the standard strategy for identification of Ig/TCR targets for minimal residual disease diagnostics in B-cell precursor ALL pediatric patients: Polish experience.
    Dawidowska M; Jółkowska J; Szczepański T; Derwich K; Wachowiak J; Witt M
    Arch Immunol Ther Exp (Warsz); 2008; 56(6):409-18. PubMed ID: 19043668
    [TBL] [Abstract][Full Text] [Related]  

  • 25. TCRB gene rearrangements in childhood and adult precursor-B-ALL: frequency, applicability as MRD-PCR target, and stability between diagnosis and relapse.
    van der Velden VH; Brüggemann M; Hoogeveen PG; de Bie M; Hart PG; Raff T; Pfeifer H; Lüschen S; Szczepański T; van Wering ER; Kneba M; van Dongen JJ
    Leukemia; 2004 Dec; 18(12):1971-80. PubMed ID: 15470492
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differences in immunoglobulin heavy chain gene rearrangmeent patterns between bone marrow and blood samples in childhood precursor B-acute lymphoblastic leaukemia at diagnosis.
    Beishuizen A; Verhoeven MA; Hählen K; van Wering ER; van Dongen JJ
    Leukemia; 1993 Jun; 7(6):60-3. PubMed ID: 8315958
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Detection of immunoglobulin kappa light-chain gene rearrangement patterns by Southern blot analysis.
    Beishuizen A; Verhoeven MA; Mol EJ; van Dongen JJ
    Leukemia; 1994 Dec; 8(12):2228-36; discussion 2237-9. PubMed ID: 7808012
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Detection of antigen receptor gene rearrangements in lymphoproliferative malignancies by fluorescent polymerase chain reaction.
    Kerlan-Candon S; Soua Z; Lefranc MP; Clot J; Eliaou JF
    Tissue Antigens; 1998 Jan; 51(1):20-9. PubMed ID: 9459500
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Analyses of the rearrangement of T-cell receptor- and immunoglobulin genes in the diagnosis of lymphoproliferative disorders].
    Griesser DH
    Veroff Pathol; 1995; 144():1-109. PubMed ID: 7856305
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Analysis of minimal residual disease in childhood acute lymphoblastic leukemia: comparison between RQ-PCR analysis of Ig/TcR gene rearrangements and multicolor flow cytometric immunophenotyping.
    Malec M; van der Velden VH; Björklund E; Wijkhuijs JM; Söderhäll S; Mazur J; Björkholm M; Porwit-MacDonald A
    Leukemia; 2004 Oct; 18(10):1630-6. PubMed ID: 15295608
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Oligoclonal immunoglobulin heavy-chain and T-cell receptor delta rearrangements persist in a recurrent acute lymphoblastic leukemia with one immunoglobulin kappa rearrangement as a clonal marker.
    Stolz F; Panzer S; Fischer S; Panzer-Grümayer ER
    Mod Pathol; 1999 Aug; 12(8):819-26. PubMed ID: 10463485
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Low frequency of clonotypic Ig and T-cell receptor gene rearrangements in t(4;11) infant acute lymphoblastic leukaemia and its implication for the detection of minimal residual disease.
    Peham M; Panzer S; Fasching K; Haas OA; Fischer S; Marschalek R; Gadner H; Panzer-Grümayer ER
    Br J Haematol; 2002 May; 117(2):315-21. PubMed ID: 11972513
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rapid and reliable quantification of minimal residual disease in acute lymphoblastic leukemia using rearranged immunoglobulin and T-cell receptor loci by LightCycler technology.
    Nakao M; Janssen JW; Flohr T; Bartram CR
    Cancer Res; 2000 Jun; 60(12):3281-9. PubMed ID: 10866322
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The incidence of T-cell receptor gene rearrangements in childhood B-lineage acute lymphoblastic leukemia is related to immunophenotype and fusion oncogene expression.
    Meleshko AN; Belevtsev MV; Savitskaja TV; Potapnev MP
    Leuk Res; 2006 Jul; 30(7):795-800. PubMed ID: 16386788
    [TBL] [Abstract][Full Text] [Related]  

  • 35. IgH/TCR delta PCR oligonucleotide liquid hybridization, a fast and sensitive assay for monitoring minimal residual disease in childhood B-precursor ALL.
    Steenbergen EJ; Verhagen OJ; van Leeuwen EF; van den Berg H; Behrendt H; von dem Borne AE; van der Schoot CE
    Leukemia; 1995 Jan; 9(1):216-22. PubMed ID: 7845021
    [TBL] [Abstract][Full Text] [Related]  

  • 36. T cell receptor gamma (TCRG) gene rearrangements in T cell acute lymphoblastic leukemia refelct 'end-stage' recombinations: implications for minimal residual disease monitoring.
    Szczepański T; Langerak AW; Willemse MJ; Wolvers-Tettero IL; van Wering ER; van Dongen JJ
    Leukemia; 2000 Jul; 14(7):1208-14. PubMed ID: 10914544
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Immunoglobulin super-gene family and its related genes in detecting MRD in ALL].
    Dong S; Kuang S; Huang W
    Zhonghua Yi Xue Za Zhi; 1996 Oct; 76(10):742-6. PubMed ID: 9275514
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chromosome 14 copy number-dependent IGH gene rearrangement patterns in high hyperdiploid childhood B-cell precursor ALL: implications for leukemia biology and minimal residual disease analysis.
    Csinady E; van der Velden VH; Joas R; Fischer S; de Vries JF; Beverloo HB; König M; Pötschger U; van Dongen JJ; Mann G; Haas OA; Panzer-Grümayer ER
    Leukemia; 2009 May; 23(5):870-6. PubMed ID: 19148138
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Real-time quantitative PCR for the detection of minimal residual disease in acute lymphoblastic leukemia using junctional region specific TaqMan probes.
    Pongers-Willemse MJ; Verhagen OJ; Tibbe GJ; Wijkhuijs AJ; de Haas V; Roovers E; van der Schoot CE; van Dongen JJ
    Leukemia; 1998 Dec; 12(12):2006-14. PubMed ID: 9844931
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Minimal residual disease monitoring in adult T-cell acute lymphoblastic leukemia: a molecular based approach using T-cell receptor G and D gene rearrangements.
    Gameiro P; Mortuza FY; Hoffbrand AV; Foroni L
    Haematologica; 2002 Nov; 87(11):1126-34. PubMed ID: 12414341
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.